The real-time multiparametric network of Campi Flegrei and Vesuvius

Volcanic processes operate over a wide range of time scale that requires different instruments and techniques to be monitored. The best approach to survey a volcanic unrest is to jointly monitor all the geophysical quantities that could vary before an eruption. The monitoring techniques are sometimes peculiar for each volcano, which has its own behavior. The simultaneous investigation of all the geophysical and geochemical parameters improves the sensibility and the understanding of any variation in the volcanic system. The Osservatorio Vesuviano is the INGV division charged of the Campi Flegrei and Vesuvius monitoring, two of the highest risk volcanic complexes in the world due to the large number of people living on or close to them. Each of them have peculiarities that increase the monitoring challenge: Campi Flegrei has high anthropic noise due to people living within its numerous craters; Vesuvius has a sharp topography that complicates the data transmission and analysis. The real time monitoring of the two areas involves several geophysical fields and the data are transmitted by a wide data-communication wired or radio infrastructure to the Monitoring Centre of Osservatorio Vesuviano: - The seismic network counts of 20 station sites in Campi Flegrei and 23 in Vesuvius equipped with velocimetric, accelerometric and infrasonic sensors. Some of them are borehole stations. - The GPS network counts of 25 stations operating at Campi Flegrei caldera and 9 stations at Vesuvius volcano. All the procedures for remote stations managing (raw data downloading, data quality control and data processing) take place automatically and the computed data are shown in the Monitoring Centre. - The mareographic network counts of 4 stations in the Campi Flegrei caldera coast and 3 close to the Vesuvius that transmit to the Monitoring Centre where the data are elaborated. - The tiltmetric network consist of 10 stations distributed around Pozzuoli harbor, the area of maximum ground uplift of Campi Flegrei, evidenced since 2005, and 7 stations distributed around the Vesuvius crater. Each tiltmetric station is also equipped with a temperature and magnetic sensor. The signals recorded are sent to the Monitoring Centre. - The 4 marine multiparametric stations installed in the Pozzuoli gulf send accelerometric, broad band, hydrophonic and GPS data to the Monitoring Centre. - The geochemical network counts of 4 multiparametric stations in the fumarolic areas of Campi Flegrei and 2 stations in the Vesuvius crater (rim and bottom) with data transmission to the Monitoring Centre. They collect soil CO2 flux, temperature gradient and environmental and meteorological parameters and transmit them directly to the Monitoring Centre. - The permanent thermal infrared surveillance network (TIRNet) is composed of 6 stations distributed among Campi Flegrei and Vesuvius. The stations acquire IR scenes at night-time of highly diffuse degassing areas. IR data are processed by an automated system of IR analysis and the temperatures values are sent to the Monitoring CentrePublishedVienna, Austria1IT. Reti di monitoraggio e sorveglianz

Morphology of the toe flexor muscles in older people with toe deformities

Objective: Despite suggestions that atrophied, or weak toe flexor muscles are associated with the formation of toe deformities, there has been little evidence to support this theory. This study aimed to determine whether the size of the toe flexor muscles differed in older people with and without toe deformities. Methods: Forty-four older adults (>60 years) were recruited for the study. Each participant had their feet assessed for the presence of hallux valgus or lesser toe deformities. Intrinsic and extrinsic toe flexor muscles were imaged with an ultrasound system using a standardised protocol. Assessor blinded muscle thickness and cross-sectional area was measured using Image J software. Results: Participants with lesser toe deformities (n=20) were found to have significantly smaller quadratus plantae (p=0.003), flexor digitorum brevis (p=0.013), abductor halluces (p=0.004) and flexor halluces brevis (p=0.005) muscles than the participants without any toe deformities (n=19). Female participants with hallux valgus (n=10) were found to have significantly smaller abductor hallucis (p=0.048) and flexor halluces brevis (p=0.013) muscles than the female participants without any toe deformities (n=10; p<0.05). Conclusion: This is the first study to use ultrasound to investigate the size of the toe flexor muscles in older people with hallux valgus and lesser toe deformities compared to otherwise healthy older adults. The size of the abductor hallucis and flexor hallucis brevis muscles were decreased in participants with hallux valgus whereas the quadratus plantae, flexor digitorum brevis, abductor hallucis and flexor halluces brevis muscles were smaller in those participants with lesser toe deformities

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum TimeCourse

Introduction: Increased cardiovascular (CV) morbidity and mortality is observed in inflammatory joint diseases (IJDs) such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. However, the management of CV disease in these conditions is far from being well established.Areas covered: This review summarizes the main epidemiologic, pathophysiological, and clinical risk factors of CV disease associated with IJDs. Less common aspects on early diagnosis and risk stratification of the CV disease in these conditions are also discussed. In Europe, the most commonly used risk algorithm in patients with IJDs is the modified SCORE index based on the revised recommendations proposed by the EULAR task force in 2017.Expert opinion: Early identification of IJD patients at high risk of CV disease is essential. It should include the use of complementary noninvasive imaging techniques. A multidisciplinary approach aimed to improve heart-healthy habits, including strict control of classic CV risk factors is crucial. Adequate management of the underlying IJD is also of main importance since the reduction of disease activity decreases the risk of CV events. Non-steroidal anti-inflammatory drugs may have a lesser harmful effect in IJD than in the general population, due to their anti-inflammatory effects along with other potential beneficial effects.This research was partially funded by FOREUM—Foundation for Research in Rheumatolog

Fetoneonatal alloimmune thrombocytopenia (FNAIT): our experience.

Fetoneonatal alloimmune thrombocytopenia (FNAIT) is a relatively rare clinical syndrome characterized by marked thrombocytopenia shortly after birth. It occurs when fetal platelets are destroyed, after sensitization, by a transplacental passage of maternal antibodies directed against a fetal platelet alloantigen inherited from the father. This article reviews some pathophysiologic and clinical aspects of FNAIT. METHODS: We also present our experience with the management of 12 newborns affected with a symptomatic form of this disorder in order to verify what would be the best diagnostic and therapeutic protocols. RESULTS: Antibody identification in maternal serum showed 9 anti-HPA-1a (75% of cases), 2 anti-HPA-1b (17%) and 1 anti-HPA-1a+anti-Gp IV+anti-HLA class I (8%). CONCLUSION: Sixteen human platelet alloantigen (HPA) systems have been identified, six major (from HPA 1 to 5 and HPA 15) and ten rare or private, each composed of two allelic antigens (named "a" or "b", according to major or minor frequency in the population). All HPA systems, including private or low frequency, may play a role in determining FNAIT. Unfortunately FNAIT cannot be prevented, in fact no one of maternal parameters is predictive of thrombocytopenia or its magnitude

Pain management in cryoglobulinaemic syndrome

Cryoglobulinaemic syndrome (CS) includes clinical signs and symptoms that range from the classic triad of Meltzer and Franklin (purpura, weakness and arthralgias) to multiple organ involvement, and it may be characterised by nociceptive or neuropathic pain. Both types of pain use the same pathways and neurotransmitters, but nociceptive pain has an adaptive system and biological function whereas neuropathic pain does not. Managing CS means dealing with often very different clinical patterns, activity and severity with the aim of preventing irreversible organ damage, reducing pain, improving the patients' quality of life and reducing social costs. However, treatment is still largely empirical, and it is often delayed. The Italian Group for the Study of Cryoglobulinaemia (GISC) strongly recommended a low-antigen-content diet and colchicine for all symptomatic CS patients. Patients with mild-moderate symptoms (such as purpura, weakness, arthralgia and initial neuropathy) have been treated with low or medium doses of steroids, and, in the presence of chronic hepatitis C virus (HCV)-related hepatitis, an attempt has been made to eradicate HCV with pegylated interferon plus ribavirin. In the case of severe or rapidly progressive disease (glomerulonephritis, neuropathy, leg ulcers, widespread vasculitis or hyperviscosity syndrome), more aggressive treatment should be used (e.g., high doses of corticosteroids, plasma exchange plus cyclophosphamide or rituximab). Pain management in CS therefore depends on the type of pain (nociceptive, neuropathic or mixed), the characteristics of the patients and their co-morbidities. Drug therapy should be carefully monitored in order to obtain prompt and beneficial results